Invited Speakers


Professor Tony Futerman, Weizmann Institute of Science, Israel

Professor Tony Futerman received his BSc degree in Biochemistry from the University of Bath, England in 1981, and his PhD degree from the Weizmann Institute of Science (Rehovot, Israel) in 1986. From 1987 to 1990, he was a postdoctoral fellow at the Carnegie Institution (Baltimore, USA). In 1990, he joined the staff of the Weizmann Institute and he is currently the Joseph Meyerhoff Professor of Biochemistry in the Department of Biomolecular Sciences. Professor Futerman's main focus is understanding how sphingolipid metabolism is regulated in both the biosynthetic and degradative pathways, with defects in the latter causing some human genetic diseases such as Gaucher disease. More recently, he has become interested in studying the likelihood that generally accepted evolutionary pathways could lead to the development of the complexity seen in the sphingolipid metabolic pathway. He has published close to 300 manuscripts. He chaired the Gordon conference on Glycolipid and Sphingolipid Biology in 2006, the Lysosomal Diseases Gordon Conference in 2011, and chaired the Molecular Medicine of Sphingolipids meeting in 2012 and 2018. Between 1995-2000 he was a member of the editorial board of the Journal of Neurochemistry, and a member of the editorial board of the Journal of Biological Chemistry from 2000 to 2012. Recently, he started a new journal, BioCosmos: new perspectives on the origin and evolution of life.


Associate Professor Michael Marty, The University of Arizona, USA

Dr. Michael Marty is an Associate Professor of Chemistry & Biochemistry at The University of Arizona. Dr. Marty earned his B.A. in chemistry and mathematics at St. Olaf College in 2010. He then completed his Ph.D. in chemistry as a Springborn Fellow at the University of Illinois Urbana-Champaign with Prof. Stephen Sligar in 2013 and went on to postdoctoral research at the University of Oxford with Prof. Dame Carol Robinson. He joined the faculty at The University of Arizona in 2016. His research applies lipid nanodiscs with mass spectrometry to study membrane proteins, antimicrobial peptides, and their interactions with lipid bilayers.


Professor Markus Wenk, National University of Singapore, Singapore

Markus Wenk has been interested in membrane lipids, their structure and function since his undergraduate years at the Biozentrum of the University of Basel. At Yale he introduced and established techniques for analysis of phospholipid metabolism at the neurological nerve terminal. Since then he has been spearheading novel approaches in systems scale analysis of lipids and their interactors (lipidomics) and is recognized as a thought leader in this field. His main scientific focus is determination and understanding of natural biological variation of circulating metabolites and lipids beyond the well-known examples of cholesterol. He is Provost’s Chair Professor, Department of Biochemistry, Yong Loo Lin School of Medicine, founder and Director of the Singapore Lipidomics Incubator (SLING) at the National University of Singapore (NUS) as well as Director of the newly formed Precision Medicine Translational Research Program NUS.



Professor Lisa Butler, University of Adelaide

Dr Tamim Darwish, ANSTO

Associate Professor Anthony Don, University of Sydney

Dr Shane Ellis, University of Wollongong

Dr Jacob Qi, University of Sydney

Professor Ute Roessner, Australian National University

Dr Jennifer Saville, SA Pathology

Dr Surinder Singh, CSIRO